BrainXell Therapeutics is a regenerative medicine company developing disease-modifying personalized cell therapies, with a focus on neurological indications. BrainXell Therapeutics utilizes proprietary methods for reprogramming and directing cells into specific lineages of the nervous system. The result is autologous cell therapies highly enriched for the target cell types of choice, including the first product candidates already in development for Parkinson’s Disease and spinal cord injury.